Cassava Sciences | PTIE - Ordinary Share Capital


Cassava Sciences reported $48.31M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Amgen USD 540M 1000K Mar/2026
Biogen USD 146.7M 200K Sep/2025
Cara Therapeutics USD 9.38M 9.38M Sep/2025
Cassava Sciences USD 48.31M 0 Dec/2025
Eisai JPY 282.11M 0 Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Geron USD 640.9M 2.54M Mar/2026
J&J USD 2.41B 1.74M Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Novartis USD 1.91B 60K Mar/2026
Novavax USD 162.58M 106K Dec/2025
Pfizer USD 5.7B 13M Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025